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February 1, 2011:634–6o the extraction, which in highly experienced hands has now been
hown to be minimal. It is now our practice in patients undergoing
ulse generator replacement who require ongoing defibrillator
herapy and who do not have substantial life-limiting comorbidi-
ies to recommend removal and replacement of the Fidelis lead
ecause later removal after lead failure is more likely to be difficult
nd associated with a higher risk of complications (1). We agree
ith the editorialists regarding the need to offer individualized
dvice regarding lead management (5), but we believe that the
nus has now shifted in favor of routine extraction, and failure to
emove this potentially dangerous lead in individual patients under-
oing pulse generator replacement should now be the exception and
ot the rule. Optimal patient care mandates that such patients be
eferred to experienced centers for extraction, and this condition
hould be a fundamental feature of any revised guidelines.
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eply
e thank Dr. Martin and colleagues for their interest in our paper
1) and commend the authors on their similarly successful experi-
nce with transvenous lead extraction (TLE) of the Medtronic
print Fidelis implantable cardioverter-defibrillator (ICD) lead
Medtronic, Minneapolis, Minnesota). Their reported success
llustrates that TLE of the Sprint Fidelis ICD lead can be a safe
rocedure in select patients and experienced hands.Furthermore, we appreciate the authors’ support of our conten-
ion that in select patients and experienced hands, the current
ecommendations regarding Sprint Fidelis ICD lead extraction
arrant reconsideration. In fact, our practice regarding the man-
gement of the Sprint Fidelis lead at the time of pulse generator
eplacement is similar to that described by the authors; among
atients undergoing pulse generator replacement “who require
ngoing defibrillator therapy and who do not have substantial
ife-limiting comorbidities,” we offer TLE after a frank discussion
egarding the risks and benefits of all potential management
trategies for the Sprint Fidelis ICD lead, including continued
onitoring, lead revision, and extraction with lead replacement.
lthough concerns regarding potential future lead failure certainly
nter the equation, our rationale for this approach is primarily
riven by the significant increasing need for countertraction sheath
ssistance with each additional month of implant duration (1),
mplying more difficulty and potentially more risk with TLE of the
print Fidelis ICD lead over time.
We remain steadfast in our assertion that decisions regarding
xtraction of the Sprint Fidelis ICD lead must be made on a
ase-by-case basis considering multiple patient- and physician-
elated variables because TLE has the potential for significant
orbidity and mortality and may not be warranted in patients with
poor prognosis or where the risks of intervention clearly outweigh
he benefits. Moreover, we reiterate that lead extractions should
ot be performed by those inexperienced in the procedure, by those
ithout the necessary tools available to attain complete success, or
n a setting not prepared and committed to the complete and safe
erformance of the procedure.
Melanie Maytin, MD
harles J. Love, MD
vi Fischer, MD
oger G. Carrillo, MD
uan D. Garisto, MD
aria Grazia Bongiorni, MD
uca Segreti, MD
oy M. John, MD, PhD
regory F. Michaud, MD
hristine M. Albert, MD, MPH
aurence M. Epstein, MD
Brigham & Women’s Hospital
5 Francis Street
oston, Massachusetts 02115
-mail: mmaytin@partners.org
doi:10.1016/j.jacc.2010.10.013
EFERENCE
. Maytin M, Love CJ, Fischer A, et al. Multicenter experience with
extraction of the Sprint Fidelis implantable cardioverter-defibrillator
lead. J Am Coll Cardiol 2010;56:646–50.
